We provide you with 20 years of free, institutional-grade data for BLRX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BLRX. Explore the full financial landscape of BLRX stock.
| Reported Date | CIK | Ticker | Type |
|---|
BioLineRx Ltd(NASDAQ:BLRX) 
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. Its development pipeline consists of clinical-stage therapeutic candidates, which include BL-8040, a peptide for the treatment of solid tumors, hematological malignancies, and stem cell mobilization; AGI-134...
Website: http://www.biolinerx.com
Founded: 2003
Full Time Employees: 42
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about BLRX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.